In addition to providing review for all human subjects research performed at Emory University, the Emory IRB is also the IRB of record for the Emory Healthcare System and the Atlanta VA Medical Center. We also review all non-expedited Emory research at Children's Healthcare of Atlanta and all Emory reseach in the Grady Health System. In addition, we have long-standing collaborations with the American Cancer Society and the Centers for Disease Control and Prevention. As a result, the majority of IRB protocols at Emory are biomedical research and the majority of pages on this website address the concerns of biomedical researchers.
It's important to note that biomedical research, like all human subjects research, can fall under any of the three types of IRB review:
The decision as to what kind of review a study initially undergoes cannot be made by the investigator. An IRB analyst will assign a study to a particular type of review in accordance with federal regulations. From there the Board or Designated Review will determine what sort of future review the study will undergo.
Given the nature of biomedical research, most studies with any sort of intervention end up being initially reviewed by the fully convened IRB. Therefore, biomedical studies should be submitted to the IRB well ahead of other required reviews (e.g grant deadlines).
Additional resources for biomedical researchers can be found on our Policies, Training, and Forms pages. Please note that all biomedical researchers are required to pass Emory's Biomedical CITI course.